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In this work, we present a simple and efficient method for pure phase magnetite (Fe3O4) nanoparticle synthesis. The phase
structure, particle shape, and size of the samples were characterized by Raman spectroscopy (Rm), X-ray diffraction (XRD),
scanning electron microscopy (SEM), energy-dispersive X-ray (EDS), and transmission electron microscopy (TEM). The
morphology tuning was controlled by the temperature of the reaction; the nanoparticles were synthesized via the hydrothermal
method at 120°C, 140°C, and 160°C, respectively. The Rm and XRD spectra showed that all the nanoparticles were Fe3O4 in a
pure magnetite phase. The obtained nanoparticles exhibited a high level of crystallinity with uniform morphology at each
temperature, as can be observed through TEM and SEM. These magnetic nanoparticles exhibited good saturation magnetization
and the resulting shapes were quasi-spheres, octahedrons, and cubes. The samples showed striking magnetic properties, which
were examined by a vibrating sample magnetometer (VSM). It has been possible to obtain a good morphological control of
nanostructured magnetite in a simple, economical, and scalable method by adjusting the temperature, without the modification
of any other synthesis parameter.
1. Introduction
Finding a novel and simple approach in order to obtain
architecturally controlled magnetic nanocrystals is a signifi-
cant challenge toward the production of future nanodevices.
Different iron oxides have been applied in many fields, but
one that draws much attention for its magnetic properties
is magnetite, mainly due to the presence of cations in two
different states of oxidation within the same crystal lattice
[1–6], also due to it having different characteristics at a
nanostructural level, depending on the morphology and size
of the particles, which can be exploited in both medicine and
biotechnology [7–10].
There are several synthesis methods used to produce
magnetite nanoparticles. The most used method to obtain
magnetite nanoparticles is coprecipitation which usually
employs Fe2+ and Fe3+ chlorides, as precursor salts, with an
ammonium hydroxide solution. This process is simple and
fast; nevertheless, the presence of more than one iron oxide
phase is a common problem; size control is difficult to
achieve, and furthermore, shape tuning is a huge challenge
[11–13]. Despite this, some variations have been proposed
to improve the viability of the coprecipitation method; it
has only been possible to obtain nanoparticles with an
acceptable size distribution and phase control using other
precursor salts or oxidizing agents, but morphological
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control remains difficult. Other approaches are thermal
decomposition [14–16] and the reduction of α-Fe2O3
dispersed in a hydrogen stream at elevated temperatures
[17, 18], with which nanoparticles of approximately 10
and 50nm, respectively, can be produced. The solvother-
mal methods deserve a special mention because of the
uniform size of the nanoparticles that can be obtained; this
method typically employs a mixture of FeCl3, ethylene
glycol, and sodium acetate, which are allowed to react in
an autoclave [19, 20].
The hydrothermal/solvothermal methods have been
reported to present a better morphological control [21, 22].
With the hydrothermal synthesis, the following products
can be obtained: (a) synthesis of new phases or stabilization
of new complexes; (b) crystalline growth of several inorganic
compounds; and (c) preparation of nanostructured and
single-crystal materials with well-defined size and morphol-
ogy, for their use in specific applications. This method is
the most efficient to synthesize nanocrystals because it
exploits the solubility of some inorganic substances at certain
temperatures and high pressures. This later favors the
crystallization of the dissolved materials within the fluid
since temperature, pressure, and reaction time are the three
main physical parameters that need to be controlled or
manipulated in order to maintain good nucleation and
particle distribution [23].
As stated, several variables must be controlled during
Fe3O4 synthesis. However, the most important one to avoid
would be the material rusting and changing its phase to one
of the most stable oxides in an oxidizing environment,
hematite. To achieve this, you can work in an inert atmo-
sphere and/or use a variety of surfactants in order to protect
the surface from oxidation [24–26]. Of these surfactants,
polyethylene glycol (PEG) stands as the most used when
the desired material must be applied in the field of medicine
due to it is biocompatibility and low cost [27–29].
To date, Fe3O4 nanoparticles have been synthesized with
various morphologies such as sphere, cube, and wire, among
others. We focused our study of existing literature on the
control of the morphology by changing two or three variables
(temperature, solvent, precursor salt, reducing agent, etc.)
simultaneously within a hydrothermal or solvothermal
reaction and through the use of surfactants [30–37].
There are interesting biological applications for iron
oxides, taking advantage of their inherent magnetic proper-
ties. Since magnetic iron oxide nanoparticles coated with
PEG usually exhibit good biocompatibility, they can be used
for biological applications and are widely applied in drug
delivery carriers [38], magnetic resonance imaging contrast
agents [39], and hyperthermia for cancer cells [40], although
it is still imperative to test the biological effect of these
magnetic nanostructures on microorganisms and human cell
lines in vitro.
In this work, a simple and easy to reproduce method was
developed to synthesize nanostructured magnetite by means
of hydrothermal synthesis. The different resulting morphol-
ogies were obtained by changing the reaction temperature
(120, 140, and 160°C), without changing any other parameter
in the synthesis, taking advantage of the relationship between
temperature, reaction kinetics, and nucleation rates. In
addition, the antibacterial and cytotoxic activities of the
different resulting morphologies of magnetite nanoparticles
were determined.
2. Experimental Section
2.1. Materials. Iron (III) chloride hexahydrate (FeCl3·6H20),
polyethylene glycol (PEG 8000), and hydrazine 64% (N2H4)
were purchased from Sigma-Aldrich, while ethanol (EtOH)
was purchased from Fermont. All the chemical reagents used
in this synthesis were of reactive grade without further
purification. Deionized water was employed throughout all
of the syntheses.
2.2. Methodology. The Fe3O4 nanostructures were synthe-
sized based on previous studies [41] with the following
modifications.
A solution of 30mL water containing FeCl3·6H20
(28mM) and PEG (0.3mM) was prepared under magnetic
stirring. Subsequently, 3mL of N2H4 was added dropwise,
while the solution was stirred vigorously with a magnetic
stirrer. At the end of the hydrazine addition, a reddish solu-
tion was obtained, which was then transferred immediately
to different Teflon autoclaves and heated at different tem-
peratures (120°C, 140°C, and 160°C) in a muffle furnace
for 4 hours. Finally, the nanostructures were collected with
a magnet and washed three times with deionized water
and ethanol, then dried at 70°C for 24 hours before further
characterization and use.
2.3. Characterization
2.3.1. Raman Spectroscopy. For Rm characterization, a drop
of the sample of magnetite nanoparticles dispersed in water
was placed on a glass slide and dried at 40°C for one hour.
The Rm spectra were obtained using Micro-Raman LabRa-
man model HR-800 Jobin-Yvon Horiba with a spectral
resolution of 2 cm−1 on a He-Ne laser (632.8 nm); the power
of the laser was 25μW.
2.3.2. X-Ray Diffraction. The X-ray diffraction patterns
(XRD) were collected on a PANalytical X’Pert Pro Diffrac-
tometer MPD with a Cu-Kα source and a 2θ ranging from
25° to 70°.
2.3.3. Scanning Electron Microscopy and Energy-Dispersive
X-Ray. For the scanning electron microscopy (SEM) analysis,
Fe3O4 NPs were dispersed in isopropyl alcohol from which a
drop was taken and placed on a silicon wafer, to be observed
in a FEG Hitachi S-5500 ultra-high-resolution electron
microscope (0.4 nm at 15 kV) with a BF/DF Duo STEM
detector. A JEOL JSM-6510LV, operated at an acceleration
voltage of 20 kV, with a tungsten filament, is attached to an
oxford energy scattering probe with a resolution of 137 eV,
where the energy-dispersive X-ray (EDS) studies were
carried out.
2.3.4. Transmission Electron Microscopy, High-Resolution
Transmission Electron Microscopy, and Selected Area
Electron Diffraction. One drop of each sample, dispersed in
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isopropyl alcohol, was placed in a copper grid coated with
carbon, then let to air dry in order to be analyzed in the
TEM microscope, a JEOL JEM-2010F equipped with a field
emission gun and operated at 200 kV with 0.1 nm lattice
resolution, which carried out the TEM and HRTEM studies.
A JEOL-2100 with a LaB6 filament was used to perform the
SAED studies.
2.3.5. Magnetic Measurements.Magnetic measurements were
run at room temperature using a magnetometer (Versalab
Crio Free VSM, Quantum Design) with a maximum applied
field of Hmax = 20 kOe.
2.3.6. Antibacterial Activity. For the antibacterial activity, we
followed the methods of Argueta-Figueroa et al. [42]. The
bacterial strains used in this study were provided by Facultad
de Medicina, Universidad Nacional Autónoma de México
(UNAM). The strains used are endemic to the region of
central Mexico and each one was characterized by a battery
of cultural and biochemical tests. The experiments on the
antimicrobial activity were carried out as described by the
Clinical and Laboratory Standards Institute [43]. Antimicro-
bial activity of the Fe3O4 nanoparticles was tested against
the human pathogenic bacteria Staphylococcus aureus (S.
aureus), Escherichia coli (E. coli), and Enterococcus faecalis
(E. faecalis) by determining the minimal inhibitory concen-
tration (MIC) and the minimal bactericidal concentration
(MBC), following the broth dilution method. Selective media
were used to culture each strain and were afterwards culti-
vated in nonselective medium. Each strain was incubated at
37°C for 24 h for the fresh bacterial cultures, which were used
to prepare McFarland standards. McFarland standards were
diluted in a 1 : 20 relation using saline solution. In 96-well
microplates, 100μL of Mueller-Hinton broth medium
(Sigma-Aldrich, St. Louis, MO, USA) was placed in each
well, and then 100μL of the synthesized Fe3O4 nanoparti-
cles (quasi-spheres, octahedrons, or cubes, respectively) at
a concentration of 5mg/mL, (previously dissolved in
Mueller-Hinton broth and sonicated for 30min) was stirred
in. At this point in time, serial dilutions were performed.
We used a positive growth control for the bacteria and a
negative growth control for the sterile broth and the nano-
particles. Each well was inoculated aseptically with 5μL of
the respective bacterial suspension (the final concentration
was approximately 5× 105 CFU/mL). Tests were performed
in four wells for each concentration and strain. The inocu-
lated microplates were incubated at 37°C for 24h and stirred
at 200 rpm in an incubator. The supernatant was transferred
to new 96-well microplates to avoid interference with the
reading due to the precipitated nanoparticles. Optical density
was read on a microplate reader (Thermo Scientific, St. Louis,
MO, USA) at 595nm. The results were expressed as a per-
centage of the viable bacteria compared with the untreated
controls. A minimal concentration, that showed no turbidity
(absence of turbidity at naked eye), was recorded as the MIC
of the Fe3O4 nanoparticles. 5μL of dilution from the wells
was subcultured on Mueller-Hinton agar plates to corrobo-
rate the data obtained from the aforementioned optical
density reading.
2.3.7. Cytotoxicity Evaluation
(1) Cell Culture. In order to evaluate the cytotoxicity, we
followed the methods reported by Argueta-Figueroa et al.
[42], as follows: human gingival fibroblast (HGF), human
pulp cells (HPC), and human bone cells (HBC) were pre-
pared from gingival, pulp, and bone tissues obtained from a
25-year-old patient based on prior written informed consent
and approval from the bioethics committee of the Escuela
Nacional de Estudios Superiores (ENES) Unidad León,
UNAM. Tissues were cut into small fragments using a surgi-
cal blade and fragments were seeded onto 10 cm culture
dishes and cultured in an Alpha Modification of Eagle’s
Medium (α-MEM, Life Technologies Gibco, Carlsbad, CA,
USA) supplemented with 20% fetal bovine serum (FBS,
Life Technologies Gibco), 100 UI/mL penicillin, 100mg/mL
streptomycin (FBS, Life Technologies Gibco), and 1% of
Glutamax (Life Technologies Gibco). The primary cultures
were incubated at 37°C in a humidified atmosphere of 5%
CO2 until the cell population covered 80% of the plate,
approximately at 21 days of cultivation. Cells were then har-
vested by treatment with 0.25% trypsin-0.025% EDTA-2Na
in PBS and either subcultured or used for experiments. Cells
were subcultured in Dulbecco’s Modified Eagle Medium
(DMEM, Life Technologies Gibco) supplemented with 10%
FBS and antibiotics under 95% of humidified atmosphere
with 5% CO2.
(2) Assay for Cytotoxic Activity. HGF, HPC, and HBC
(1× 105 cells/mL) were inoculated into each well of
96-microwell plates and incubated for 48 h to achieve com-
plete cell adherence and proliferation. The different Fe3O4
nanoparticles (quasi-spheres, octahedrons, or cubes) were
inoculated at different concentrations at 5, 2.5, 1.25, 0.625,
0.3125, 0.15625, and 0.078125mg/mL and incubated for a
further 24 h. The relative viable cell count was deter-
mined by the MTT assay (Sigma-Aldrich, St. Louis, MO,
USA). Afterwards, the culture medium was replaced with
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) (0.2mg/mL) dissolved in DMEM, and cells were
incubated for 4 h at 37°C. After replacing the medium, the
formazan product was dissolved in dimethyl sulfoxide
(DMSO, Sigma-Aldrich, St. Louis, MO, USA). As viable
cells remain in the bottom of the wells, the supernatant
was therefore removed and the cells washed three times
before the well readings were carried out. The optical absor-
bance at 570 nm of the lysate was determined by using a
microplate reader (Thermo Scientific, St. Louis, MO,
USA). The cytotoxicity test was performed for each nano-
particle sample in triplicate independent experiments
according to ISO 10990-5 Biological evaluation of medical
devices—Part 5: Tests for in vitro cytotoxicity.
3. Results and Discussion
Figure 1 shows a photograph of the particles dispersed in
water; here the characteristic dark color of the magnetite
and the appropriate response to contact with a magnet are
observed. In Figure 1(b), it can be seen that the particles are
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stable in colloidal solution. This behavior is the same for
all samples.
3.1. Raman Spectroscopy. Rm spectroscopy is a characteriza-
tion technique used to accurately identify different iron oxide
phases within the samples. Magnetite has an inverse spinel
structus above 119°K, resulting in five Raman bands: three
T2G, one A1g, and one Eg, respectively [44]. While in ambient
conditions, the nonpolarized spectra of magnetite show four
of the five bands at 668, 538, 306, and 193 cm−1, the last one
appears very weakly and has only been reported a few
times [45]. A summary of the Raman shift associated with
magnetite is shown in Table 1.
After the nanoparticle suspensions were dripped on glass
slides, Rm spectra of three samples were collected (as shown
in Figure 2) using a low laser intensity (25μW) in order to
prevent oxidation of the samples caused by overheating.
Although laser intensity is required to improve the high
quality of the Rm spectra, the use of a considerably larger
intensity has been found to oxidize the samples of magnetite,
even when the nanoparticles are coated. This can affect the
crystalline structure, and the Raman bands associated with
hematite could appear at 226, 245, 292, 411, 497, and
612 cm−1 [52].
Figure 2 shows the Rm spectra of the magnetite nanopar-
ticles synthesized of three different temperatures. The
vibrational spectra analysis can be described based on the
structure of the spinel magnetite. In Figure 2, the most
intense band observed in all three samples is centered at
667 cm−1, and it corresponds to the symmetrical stretching
of the oxygen atoms along the Fe-O bonds in the tetrahedral
sites of the molecule (A1g). The difference in intensity may be
associated with particle morphology as the band at around
540 cm−1 can be associated to the asymmetrical stretching
of the Fe-O bond (T2G). However, the intensity is too low
which suggests that some PEG remains on the surface of
the nanoparticle.
3.2. X-Ray Diffraction. The presence of other iron oxide
phases, like maghemite, remains a challenge for many syn-
thetic methods. Furthermore, the structural characterization
of these materials with nanometric regime must be supported
by several techniques in order to identify the present phases,
in addition to the size and morphology of the nanoparticles.
For this reason, in order to support the Raman studies, the
(a) (b) (c)
Figure 1: Photograph of nanoparticles obtained at synthesis hydrothermal at 140°C.
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Figure 2: Rm spectra of magnetite nanoparticles synthesized at
different temperatures. (a) 120°C. (b) 140°C. (c) 160°C.
4 Journal of Nanomaterials
samples were also analyzed by XRD to complement phase
identification of the iron oxide in all three samples.
The XRD patterns of the magnetite nanoparticles synthe-
tized at different temperatures, which are shown in Figure 3,
reveal that the 2θ diffraction peaks at 30.38°, 35.72°, 43.40°,
53.70°, 57.28°, and 62.79° can be indexed as the (220), (311),
(400), (422), (511), and (440) reflections, respectively, corre-
sponding to the cubic spinel structure of magnetite (Fe3O4).
These characteristic peaks were a perfect match with the
standard JCPDS card no. 19-0629, associated with a face
center cubic (FCC) cell structure with a lattice constant
of a = 8 393 Å and a Fd3m space group. Here, half of the tri-
valent ions (Fe3+) are in the tetrahedral (A) sites, and the
other half of the trivalent and all the divalent ions (Fe2+)
are randomly distributed in the octahedral (B) interstices.
The parallel alignment of Fe2+ and Fe3+ ions spins in adjacent
octahedral sites which leads to a net magnetization and a fer-
rimagnetic behavior.
In the XRD pattern in Figure 3(b), which corresponds to
the magnetite synthesized at 140°C, it can be seen that the
diffraction peaks are wider than those of the other two sam-
ples. This profile can be explained by considering a large
crystallite size range, the presence of lattice strain, a crystallite
imperfection (micro strains, d-spacing fluctuations, stack-
ing faults), and/or instrumental defects [53]. Furthermore,
geometrical properties and size polydispersity of this sam-
ple can add variables that also cause a broadening of the
Bragg reflection.
3.3. Scanning Electron Microscopy and Energy-Dispersive
X-Ray. Table 2 shows the elemental analysis obtained via
EDS studies of the magnetite nanoparticles synthesized at
different temperatures, with which we can confirm the
presence of each of the elements that make up the material.
The following results were obtained by weight percent
(%w): Fe %w was associated with iron oxide, C %w to the
surfactant, and O %w was associated in part to the oxide
and another part to the surfactant.
The morphology of the nanoparticles obtained in synthe-
sis at the different temperatures was observed by SEM, as
seen in Figure 4. The sample synthesized at 120°C presents
a nonuniform morphology where the majority of the observ-
able shapes are polyhedral or quasi-spherical (Figures 4(a)
and 4(d)). Well-defined octahedral particles are shown in
the micrographs of the particles synthesized at 140°C
(Figures 4(b) and 4(e)). When synthesis occurs at 160°C, a
contrasting morphology of predominantly truncated cubes
can be seen (Figures 4(c) and 4(f)).
Although the three syntheses were performed under
the same conditions, only varying the reaction tempera-
ture, the change in morphology is notorious. This can
be explained by the nucleation rate of chemical species due
to higher temperatures promoting more collisions between
particles, leading into larger and more homogeneously
shaped particles.
3.4. Transmission Electron Microscopy, High-Resolution
Transmission Electron Microscopy, and Selected Area
Electron Diffraction. The results obtained through both




























Figure 3: XRD patterns of Fe3O4 nanoparticles at different temperatures. (a) 120
°C. (b) 140°C. (c) 160°C.




C 15.11 14.16 14.38
O 43.37 44.18 44.37
Fe 41.52 41.66 41.25
Total 100.00 100.00 100.00
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microscopic techniques are complementary. This is due to
SEM working at a lower resolution so it can be used to
observe the samples in a larger scale, which can lead to a
statistical perspective; whereas through TEM, which works
at much lower resolutions (HRTEM), we can obtain informa-
tion about crystalline growth, orientation, and morphology
of single particles.
In order to explore the particle size distribution, more
than 100 particles were measured in different micrographs
for each sample (Figure 5). In spite of the particle shape being
easy to control by changing the temperature used in this
method, the size distribution was wide for all samples, from
10 to 65 nm (quasi-spheres), 15 to 465nm (octahedrons),
and 25 to 300 nm (cubes) for the magnetite obtained at
120°C, 140°C, and 160°C, respectively. These results show
that the widest size range belongs to the magnetite obtained
at 140°C, which is in accordance with the expected
behavior of the XRD pattern of octahedron particles, as
described above.
The experiments demonstrate that the temperature
increase promotes a change in the morphology of the
particles, as evidenced by SEM and TEM micrographs. The
quasi-spheres, octahedrons, and cubes seen in the SEM
micrographs on Figure 4 can also be observed in the TEM
micrographs on Figure 6. Here, we can observe that all of
the three synthesized Fe3O4 nanoparticles displayed uniform
morphologies, a trait which closely relates to the tempera-
tures used throughout the synthesis of the samples.
TEM and SEMmicrographs confirm that a homogeneous
shape control of the magnetite nanoparticles can be obtained
with the developed synthesis method (Figures 6(a)–6(c)). The
HRTEM image shown in Figure 6(d) exhibits planes with
interplanar distances of 0.48 nm and 0.29 nm which corre-
spond with the (111) and (220) reflection planes of magne-
tite; the interplanar distances of 0.48 nm in Figures 6(e) and
6(f) correspond to the distance associated with the (111)
reflection planes of the inverse spinel structured Fe3O4.
Selected area electron diffraction (SAED) analysis further
proves that the nanoparticles are highly crystalline magnetite
nanoparticles. The electron diffraction pattern (Figure 6(g))
presents rings confirming the quasi-spherical morphology
of the particles obtained at 120°C. The [111] growth axis is
observed in the magnetite particles synthesized at 140°C
(Figures 6(e) and 6(h)), which have an octahedral shape
and, according to the literature, the (111) plane is the
















Figure 4: SEM images of magnetite nanoparticles at different temperatures. (a, d) 120°C. (b, e) 140°C. (c, f) 160°C.
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corresponding SAED pattern for the Fe3O4 cubes of the
sample synthesized at 160°C is shown in Figure 6(i), which
indicates the orientation of the cubes to be in the (111) plane.
The formation of nanoparticles with controlled morphol-
ogy has always been a challenge for researchers, since many
variables must be controlled. Therefore, the main objective
of this research is to develop an easy to replicate method of
morphological control. For this reason, when controlling
the variables such as concentration, precursor salts, surfac-
tants, and solvents, the shape tuning of the nanoparticles
was modified only by the reaction temperature, which is
directly related to the kinetics of the reaction and the
nucleation rate of the nanoparticles.
When we have a face-centered cubic crystal structure
(FCC), such as with the magnetite, we can consider that the
surface energy is anisotropic in the following order:
{111}< {100}< {110}. Because of this, it is expected that the
growth of nanostructured magnetite crystals may have a
tendency to grow in an octahedral structure, considering
the more stable {111} facet, as is shown in Figures 6(e)
and 6(h). In Figure 6(d), which shows polyhedral and
quasi-spherical morphologies, we observe the {111} and
{100} facets which can be associated with the growth seeds
of the octahedral nanoparticles; the {100} facets remain pas-
sivated while the temperature increases from 120°C to 140°C.
The general idea of the growing process and morphology
transformation starts with chemical reaction of the iron pre-
cursors and hydrazine in the presence of PEG to form irreg-
ular and nonuniform Fe3O4 nanoparticles. These undergo
several successive structural transformations in order to
adapt to the most thermodynamically stable morphology;
the transformation rate depends on the temperature, the
nature of the capping agent, and the size of the particles
[52, 54]. In this case, the temperature is the key in order to
guide the shape.
Electron microscopy was employed to record and evalu-
ate the evolution of quasi-spheres into octahedrons and
finally into cubes. Sau and Rogach [55] reported that no
spherical metal seed can be turned into octahedrons or cubes
due to the similar rate of growth of the {111} and the {100}
facets; this is because when all facets grow at the same rate
only the particle size increases. However, if one of the facets
has either a lower surface energy or is blocked by capping
agents, its growth rate will be less than that of the other facet
allowing the change in morphology. However, the magnetic
nanoparticles show {111} as their external facet, as it is the
most compact and the most stable facet. Furthermore, it is
possible that octahedron morphologies could be destabilized
enough at {111}, when the temperature increases from 140°C
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Figure 5: Size distribution of the magnetite nanoparticles at different temperatures. (a) 120°C. (b) 140°C. (c) 160°C.
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produce higher nanostructures with a cubic shape. Yet, the
{111} facet remains as the external one. All the same, lengthy
studies about the mechanism of shape transformation, dur-
ing and after hydrothermal synthesis, have been considered
within the reach of this investigation. In Figure 7, a schematic
of the possible processes of the changes in the morphology
of the magnetite nanoparticles, obtained with our synthesis,
is presented.
3.5. Magnetic Measurement. The M-H loops of Fe3O4
nanoparticles synthesized at different temperatures were





































𝜈<100> > 𝜈<111>𝜈<100> ≌ 𝜈<111>
𝜈<111> > 𝜈<100>
Figure 7: Schematic of the possible growth of nanoparticles of synthesized nanoparticles.
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saturation magnetization (Ms) of the quasi-spherical nano-
particles obtained at 120°C is 52.71 emu/g; of the octahedrons
obtained at 140°C, Ms is 73.23 emu/g; lastly, for the cubes
obtained at 160°C, Ms is 107.57 emu/g. The Ms is related to
size; if the nanoparticle size is increased, the Ms will increase
as well. This phenomenon was observed in the magnetization
curves (Figure 8) where the Ms of the cubes is higher than
that of the polyhedral nanoparticles.
Another reason for the increased saturation of the
magnetization in the case of Fe3O4 cubes may be related to
the increased crystallinity (Figures 6(c), 6(f), and 6(i)), espe-
cially when comparing these results with the quasi-spherical
nanoparticles, which have a lower crystallinity (Figures 6(a),
6(d), and 6(g)). Consequently, both the shape and larger
size of the crystals in the cubic magnetite nanoparticles
caused a significantly higher magnetization value. For these
reasons, the increase in the magnetic properties may be
attributed to both the increase in the size and the crystallin-
ity of the Fe3O4 nanoparticles, as well as the morphology
obtained by increasing the temperature synthesis from
120°C to 160°C.
In addition, it was reported that Fe3O4 nanoparticles
smaller than 20nm exhibit superparamagnetism because
they contain a single domain with a single magnetic moment
with an average Ms value of 50–60 emu/g; thus, the particles
obtained from the synthesis at 120°C, in which a value of
52.71 emu/g is observed, have a superparamagnetic behavior.
The coercivity (Hc) for the polyhedral, octahedron, and cubic
nanoparticles is 36Oe, 48Oe, and 59Oe, respectively. In
general, the coercivity of magnetic materials depends on the
size, morphology, and crystalline anisotropy, and were the
size of the particles to increase, the coercivity would increase
as well due to the particle exceeding its superparamagnetic
limits (~20nm).
3.6. Antibacterial Activity. The results of the antibacterial
broth microdilution test can be seen in Figure 9. All of the
concentrations tested of the different Fe3O4 nanoparticles
(quasi-spheres, octahedrons, and cubes) showed turbidity,
which translates into a low antibacterial effect. Only the
Fe3O4 cubes showed a greater reduction of bacterial growth.
S. aureus, E. coli, and E. faecalis showed a reduction of
54.19%, 36.12%, and 20.92%, respectively, at the highest
tested concentration (5mg/mL). However, in no case was
the minimum inhibitory concentration achieved (reduction
of the inoculum to less than 95%).
A potential field, which has been postulated for the
application of iron oxide NPs, is a bactericidal drug. There
are few reports in which the antibacterial effect is argued;
particle internalization through the bacterial cell membrane
is a common antibacterial mechanism. Arokiyaraj et al. [56]
prepared iron oxide NPs treated with ethanoic extract of A.
mexicana which showed a higher activity against E. coli and
P. mirabilis than iron oxide NPs alone, but they attribute it
to the size of the nanoparticles (less than 20nm). In fact, this
pathway is strongly dependent on particle size [57], so this
mechanism is unlikely to explain the antibacterial effects of
Fe3O4 nanoparticles with octahedral and cubic morphology.
After testing, results show a slight increase in antibacte-
rial effect of the spheres when compared to the octahedral
nanoparticles, which could be attributed to the average size
of the particles. While the spheres are considerably smaller
than the octahedrons, it is possible that at least a fraction of
the total spheres (those with smaller size than 20nm) are
internalized in the bacteria, causing alterations in the cellular
metabolism and leading to death. On the other hand, the
antibacterial activity of octahedrons and cubes could be
explained as a result of the edges and vertexes present in
the nanoparticles. The shape-dependent activity has been



















Figure 8: Magnetization curves at room temperature of Fe3O4 nanoparticles. (a) 120
°C. (b) 140°C. (c) 160°C.
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explained in terms of the percent of active facets in the
nanostructures. This geometric shape may contribute in
the way of harming bacterial cell walls, causing cellular
membrane disruption [58].
It has been reported that iron oxide NPs exhibit bacterial
growth inhibition properties on a wide spectrum of bacterial
species mainly by generating reactive oxygen species (ROS)
from water or the environment [59]. However, in the present
study, the antibacterial activity of Fe3O4 nanoparticles shows
a low level of efficiency. It is likely that the ligand used (PEG)
for nanoparticle stabilizing has had a negative effect on ROS
generation, which is prevented if the Fe3O4 is not in contact
with the medium. According to the reports by El-Sigeny
and Abou Taleb, [60] the ability of the nanoparticles of
Fe3O4 to produce ROS could depend on the stabilizing agent
used; in their results, the antibacterial effect changed
markedly according to this variable.
Magnetic biomaterials provide the ability to be directed
and concentrated within the target tissue by means of an
external magnetic field and to be removed once therapy
was completed [61]. Due to this, furthermore studies are nec-
essary in the future to allow a better iron oxide nanoparticle
application in the biomedical field.
3.7. Cytotoxicity Evaluation. According to the MTT test,
following the ISO 10990-5 classification for cytotoxicity,
all the morphologies of the magnetite NPs were found
“noncytotoxic” and only those that were below 75% of rel-
ative cell viability (at the highest dose tested) are classified
as slightly cytotoxic (see Figure 10). So, it can be said that
in general all the nanoparticles tested in the present study
were biocompatible.
It has been shown that iron oxide nanoparticles are


























































Figure 9: Graph of dilution broth test against S. aureus, E. coli, and E. faecalis using Fe3O4 nanoparticles. (a) 120
°C. (b) 140°C. (c) 160°C.
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been studied for biomedical purposes. In a study performed
by Yaaghoobi et al. [62], the toxicity of commercial and
biosynthesized iron oxide NPs on peripheral blood cells
was evaluated. In their study, the iron oxide NPs obtained
by biosynthesis did not induce any morphological changes
on peripheral blood cells. Some adverse effects of iron oxide
NPs depend on their phase composition, such as Fe3O4,
γ-Fe2O3, or Fe2O3. While γ-Fe2O3 nanoparticles exhibit no
apparent cytotoxicity, the Fe3O4 nanoparticles containing
Fe2+ ions were found to be cytotoxic [63]. Studying how the
nanoparticles are recognized from a biological approach is
vital to improve their design and potential applications.
However, it has been suggested that iron oxide NPs (and
nanoparticles in general) enter into cells via endocytosis, a
mechanism that leads to cellular death due to the massive
internalization [64]. One of the major routes affecting the
survival of nanoparticles in circulation is their recognition
by the reticuloendothelial system [65]. This recognition by
the innate immune system would induce to phagocytosis of
the foreign antigen and the activation of specific antigens
mediated by B-2 cells, initiating the adaptive response [66].
The acquired antibodies allow the process of particle clear-
ance more efficient by opsonization, activation of comple-
mentary system, and by the induction of the inflammatory
response [67, 68].
Another important topic is the nanoparticle size. It
seems increasingly evident that the size is critical for their
biocompatibility and their subsequent degradation. There
is evidence that accumulation in the spleen and liver
depends directly on the particle size. When nanoparticles
are intravenously or intraperitoneally injected, inorganic
and organic nanoparticles are mainly sequestered in the
liver and spleen. Iron oxide NPs with a 150nm diameter
are accumulated in the liver and the spleen, whereas particles
having sizes below 10–15 nm are selectively filtered by the
renal system and eliminated from the organism [69, 70].
Another main concern is that the release of free iron from























































Figure 10: Graph of cell viability for human gingival fibroblast (HGF), human pulp cells (HPC), and human bone cells (HBC) in direct
contact with magnetite NPs. (a) 120°C. (b) 140°C. (c) 160°C.
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function in the production of reactive oxygen species in the
course of the Fenton reaction [71].
There are, in fact, magnetic iron oxide nanoparticles
already in the market. They are used as contrast agents
during magnetic resonance imaging (MRI) scans such as
Feridexs, (Advanced Magnetics, USA, Endorem®, Guerbet,
France; dextran-coated, hydrodynamic diameter of 120–
180nm), Ferumoxtran-10 (Combidex® in USA, Sinerem®
in Europe), among others [72]. Endorem®, as well as
carboxydextran-coated Ferucarbotran®, was specifically
approved for liver MRIs, due to affinity of the iron oxide
nanoparticles for their rapid opsonization followed by
sequestration by Kupffer cells in the liver upon intravenous
injection; as a result, their application is limited to diseases
related to phagocytic cells [73]. In contrast, it was found
that even high concentrations of Ferumoxtran-10 are not
acutely toxic to human macrophages in vitro; they do
not produce proinflammatory cytokines or superoxide
anions; they are not chemotactic nor do they interfere
with Fc-receptor-mediated phagocytosis [74]. Still, more
experimental research and in vivo studies are required to
advance composition optimization and to improve the effi-
ciency of these NPs for imaging and drug delivery applica-
tions. More thorough investigation is required to further
understand the precise mechanisms involved in the detach-
ment of these molecules from the nanoparticles (the zeta
potential charge of the bare nanoparticles which impacts
their adsorption of lipoproteins in systemic circulation, non-
specific binding, their subsequent clearance and in vivo
transport [75, 76]), their biodistribution, and their elimina-
tion mechanisms.
Some studies indicate that the clearance of iron oxide NPs
requires between 3 and 7 weeks when released in an organ-
ism, which implies that the NPs must be tracked for long
periods of time [77, 78]. The clearance time is not completely
agreed upon, possibly due to the differences in the sizes of the
iron oxide particles and the type of coating or functionalizing
molecules used. The current data point out that to prevent
this mechanism the coating/functionalization of the nano-
particles is required. For example, dextran is routinely used
for coating iron oxide NPs, because of its high affinity to
them. This coating provides steric stability to the particles,
which prevents their aggregation in an aqueous continuous
phase [67]. A certain concern about the potential immuno-
genic response of coating iron oxide NPs was found [79];
however, these NPs are more cytotoxic without coating.
In the present study, PEG was used as a particle stabilizer,
which allows the nanoparticles to be dissolved completely in
an aqueous medium along with the cell culture. The iron
oxide nanoparticles coated with PEG showed adequate
biocompatibility. Although the MTT assay is a reliable test
in vitro, these results must be confirmed in an in vivo animal
model. This would allow a possible comparison with the
aforementioned in vivo studies.
4. Conclusion
In summary, we have shown that by modifying only the
temperature of the syntheses while using the hydrothermal
method, a good morphological control of nanostructured
magnetite can be successfully obtained, where morphology
is an essential requirement to adjust magnetic properties in
different potential applications. As a result, it has been possi-
ble to obtain quasi-spheres, octahedrons, and cubes in the
nanometric regime, by adjusting the temperature to 120°C,
140°C, and 160°C, respectively, without the modification of
any other synthesis parameters, thus obtaining a simple,
economical, and scalable method for obtaining magnetic
nanoparticles. The antibacterial activity of magnetite NPs
tested shows a low level of efficiency. However, the cyto-
toxicity was “slightly cytotoxic” and “noncytotoxic.” So
the magnetite nanoparticles could potentially be used in
the biomedical field.
Data Availability
The data used to support the findings of this study are
available from the corresponding author upon request.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
Acknowledgments
The authors acknowledge the Kleberg Advanced Microscopy
Center (KAMiC) and NIH RCMI Nanotechnology and
Human Health Core (Grant 5G12RR013646-12) at Univer-
sity of Texas at San Antonio for the support with elec-
tron microscopy. The authors gratefully acknowledge Dr.
Elizande-Galindo and Dr. Farias Mancilla from UACJ for
their technical support with magnetic measurements. This
research was funded by UAEM Grant 3688/20147CIB
and CONACYT Grant 280518. The authors thank the
Cátedras-CONACYT program and the Facultad de Odon-
tología, Universidad Autónoma Benito Juárez de Oaxaca,
for their support. The authors also thank the financial
support from DGAPA-UNAM: PAPIIT-IA205518 and
PAPIME-PE208518.
References
[1] X. Yao, K. Sabyrov, T. Klein, R. Lee Penn, and T. S. Wiedmann,
“Evaluation of magnetic heating of asymmetric magnetite
particles,” Journal of Magnetism and Magnetic Materials,
vol. 381, pp. 21–27, 2015.
[2] J. Wang, A. Munir, Z. Zhu, and H. S. Zhou, “Magnetic nano-
particle enhanced surface plasmon resonance sensing and its
application for the ultrasensitive detection of magnetic
nanoparticle-enriched small molecules,” Analytical Chemistry,
vol. 82, no. 16, pp. 6782–6789, 2010.
[3] A. L. Swindle, A. S. E. Madden, I. M. Cozzarelli, and
M. Benamara, “Size-dependent reactivity of magnetite nano-
particles: a field-laboratory comparison,” Environmental Sci-
ence & Technology, vol. 48, no. 19, pp. 11413–11420, 2014.
[4] P. Majewski and B. Thierry, “Functionalized magnetite nano-
particles-synthesis, properties, and bio-applications,” Critical
Reviews in Solid State and Materials Sciences, vol. 32, no. 3-4,
pp. 203–215, 2007.
12 Journal of Nanomaterials
[5] K. Atacan, B. Çakıroğlu, and M. Özacar, “Covalent immobili-
zation of trypsin onto modified magnetite nanoparticles and
its application for casein digestion,” International Journal of
Biological Macromolecules, vol. 97, pp. 148–155, 2017.
[6] M. Aghazadeh, I. Karimzadeh, and M. R. Ganjali,
“Electrochemical evaluation of the performance of cathodi-
cally grown ultra-fine magnetite nanoparticles as electrode
material for supercapacitor applications,” Journal of Materials
Science: Materials in Electronics, vol. 28, no. 18, pp. 13532–
13539, 2017.
[7] A. Ruiz, G. Salas, M. Calero et al., “Short-chain PEG molecules
strongly bound to magnetic nanoparticle for MRI long circu-
lating agents,” Acta Biomaterialia, vol. 9, no. 5, pp. 6421–
6430, 2013.
[8] M. Mahmoudi, A. Simchi, M. Imani et al., “A new approach
for the in vitro identification of the cytotoxicity of superpara-
magnetic iron oxide nanoparticles,” Colloids and Surfaces B:
Biointerfaces, vol. 75, no. 1, pp. 300–309, 2010.
[9] M. Fazilati, “Folate decorated magnetite nanoparticles: synthe-
sis and targeted therapy against ovarian cancer,” Cell Biology
International, vol. 38, no. 2, pp. 154–163, 2013.
[10] M. Ravichandran, S. Velumani, and J. T. Ramirez,
“Water-dispersible magnetite nanoparticles as T2MR imaging
contrast agent,” Biomedical Physics & Engineering Express,
vol. 3, no. 1, article 015011, 2017.
[11] K. Petcharoen and A. Sirivat, “Synthesis and characterization
of magnetite nanoparticles via the chemical co-precipitation
method,” Materials Science and Engineering: B, vol. 177,
no. 5, pp. 421–427, 2012.
[12] R. Valenzuela, M. C. Fuentes, C. Parra et al., “Influence of
stirring velocity on the synthesis of magnetite nanoparticles
(Fe3O4) by the co-precipitation method,” Journal of Alloys
and Compounds, vol. 488, no. 1, pp. 227–231, 2009.
[13] X. Wei and R. C. Viadero Jr, “Synthesis of magnetite
nanoparticles with ferric iron recovered from acid mine drain-
age: implications for environmental engineering,” Colloids and
Surfaces A: Physicochemical and Engineering Aspects, vol. 294,
no. 1-3, pp. 280–286, 2007.
[14] D. Maity, S. N. Kale, R. Kaul-Ghanekar, J. M. Xue, and J. Ding,
“Studies of magnetite nanoparticles synthesized by thermal
decomposition of iron (III) acetylacetonate in tri(ethylene
glycol),” Journal of Magnetism and Magnetic Materials,
vol. 321, no. 19, pp. 3093–3098, 2009.
[15] D. Maity, S. G. Choo, J. Yi, J. Ding, and J. M. Xue, “Synthesis of
magnetite nanoparticles via a solvent-free thermal decomposi-
tion route,” Journal of Magnetism and Magnetic Materials,
vol. 321, no. 9, pp. 1256–1259, 2009.
[16] L. Zhang, R. He, and H. C. Gu, “Oleic acid coating on the
monodisperse magnetite nanoparticles,” Applied Surface Sci-
ence, vol. 253, no. 5, pp. 2611–2617, 2006.
[17] R. N. Panda, N. S. Gajbhiye, and G. Balaji, “Magnetic proper-
ties of interacting single domain Fe3O4 particles,” Journal of
Alloys and Compounds, vol. 326, no. 1-2, pp. 50–53, 2001.
[18] H. P. Shao, Y. M. Tan, T. Lin, and Z. M. Guo, “Size-controlled
synthesis of magnetite nanoparticles from iron acetate by
thermal decomposition,” Applied Mechanics and Materials,
vol. 217-219, pp. 256–259, 2012.
[19] P. Ou, G. Xu, C. Xu, Y. Zhang, X. Hou, and G. Han, “Synthesis
and characterization of magnetite nanoparticles by a simple
solvothermal method,” Materials Science-Poland, vol. 28,
no. 4, 2010.
[20] Y. Zhan, R. Zhao, F. Meng et al., “Oriented growth of magne-
tite along the carbon nanotubes via covalently bonded method
in a simple solvothermal system,” Materials Science and
Engineering: B, vol. 176, no. 10, pp. 779–784, 2011.
[21] A. Rabenau, “The role of hydrothermal synthesis in prepara-
tive chemistry,” Angewandte Chemie International Edition,
vol. 24, no. 12, pp. 1026–1040, 1985.
[22] P. Coppola, F. G. da Silva, G. Gomide et al., “Hydrothermal
synthesis of mixed zinc–cobalt ferrite nanoparticles: structural
and magnetic properties,” Journal of Nanoparticle Research,
vol. 18, no. 5, p. 138, 2016.
[23] K. Byrappa and M. Yoshimura, Handbook of Hydrothermal
Technology, Elsevier, 2012.
[24] J.-H. Wu, S. P. Ko, H.-L. Liu, S. Kim, J.-S. Ju, and Y. K. Kim,
“Sub 5 nm magnetite nanoparticles: synthesis, microstructure,
and magnetic properties,”Materials Letters, vol. 61, no. 14-15,
pp. 3124–3129, 2007.
[25] L. Shen, Y. Qiao, Y. Guo et al., “Facile co-precipitation synthe-
sis of shape-controlled magnetite nanoparticles,” Ceramics
International, vol. 40, no. 1, pp. 1519–1524, 2014.
[26] M. Wang, M. L. Peng, W. Cheng, Y. L. Cui, and C. Chen, “A
novel approach for transferring oleic acid capped iron oxide
nanoparticles to water phase,” Journal of Nanoscience and
Nanotechnology, vol. 11, no. 4, pp. 3688–3691, 2011.
[27] J. Zhang, S. Rana, R. S. Srivastava, and R. D. K. Misra, “On
the chemical synthesis and drug delivery response of folate
receptor-activated, polyethylene glycol-functionalized mag-
netite nanoparticles,” Acta Biomaterialia, vol. 4, no. 1,
pp. 40–48, 2008.
[28] P. Majewski and B. Thierry, “Functionalized magnetite nano-
particles—synthesis, properties, and bio-applications,” Critical
Reviews in Solid State and Materials Sciences, vol. 32, no. 3-4,
pp. 203–215, 2007.
[29] B. Feng, R. Y. Hong, L. S. Wang et al., “Synthesis of Fe3O4/
APTES/PEG diacid functionalized magnetic nanoparticles for
MR imaging,” Colloids and Surfaces A: Physicochemical and
Engineering Aspects, vol. 328, no. 1-3, pp. 52–59, 2008.
[30] L. Hou, Q. Zhang, F. Jérôme, D. Duprez, H. Zhang, and
S. Royer, “Shape-controlled nanostructured magnetite-type
materials as highly efficient Fenton catalysts,” Applied Cataly-
sis B: Environmental, vol. 144, pp. 739–749, 2014.
[31] Y. Li, R. Jiang, T. Liu, H. Lv, and X. Zhang, “Single-microemul-
sion-based solvothermal synthesis of magnetite microflowers,”
Ceramics International, vol. 40, no. 3, pp. 4791–4795, 2014.
[32] J. Sato, M. Kobayashi, H. Kato, T. Miyazaki, and M. Kakihana,
“Hydrothermal synthesis of magnetite particles with uncom-
mon crystal facets,” Journal of Asian Ceramic Societies, vol. 2,
no. 3, pp. 258–262, 2014.
[33] D. Ramimoghadam, S. Bagheri, and S. B. A. Hamid, “In-situ
precipitation of ultra-stable nano-magnetite slurry,” Journal
of Magnetism and Magnetic Materials, vol. 379, pp. 74–
79, 2015.
[34] T. J. Daou, G. Pourroy, S. Bégin-Colin et al., “Hydrothermal
synthesis of monodisperse magnetite nanoparticles,” Chemis-
try of Materials, vol. 18, no. 18, pp. 4399–4404, 2006.
[35] Z. Xu, C. Shen, Y. Hou, H. Gao, and S. Sun, “Oleylamine as
both reducing agent and stabilizer in a facile synthesis of
magnetite nanoparticles,” Chemistry of Materials, vol. 21,
no. 9, pp. 1778–1780, 2009.
[36] X. Sun, C. Zheng, F. Zhang et al., “Size-controlled synthesis of
magnetite (Fe3O4) nanoparticles coated with glucose and
13Journal of Nanomaterials
gluconic acid from a single Fe(III) precursor by a sucrose
bifunctional hydrothermal method,” The Journal of Physical
Chemistry C, vol. 113, no. 36, pp. 16002–16008, 2009.
[37] H. Zhang and G. Zhu, “One-step hydrothermal synthesis of
magnetic Fe3O4 nanoparticles immobilized on polyamide
fabric,” Applied Surface Science, vol. 258, no. 11, pp. 4952–
4959, 2012.
[38] M. Arruebo, R. Fernández-Pacheco, M. R. Ibarra, and
J. Santamaría, “Magnetic nanoparticles for drug delivery,”
Nano Today, vol. 2, no. 3, pp. 22–32, 2007.
[39] N. Lee and T. Hyeon, “Designed synthesis of uniformly sized
iron oxide nanoparticles for efficient magnetic resonance
imaging contrast agents,” Chemical Society Reviews, vol. 41,
no. 7, pp. 2575–2589, 2012.
[40] M. Bañobre-López, A. Teijeiro, and J. Rivas, “Magnetic
nanoparticle-based hyperthermia for cancer treatment,”
Reports of Practical Oncology & Radiotherapy, vol. 18, no. 6,
pp. 397–400, 2013.
[41] H. Wiogo, M. Lim, P. Munroe, and R. Amal, “Understanding
the formation of iron oxide nanoparticles with acicular struc-
ture from iron(III) chloride and hydrazine monohydrate,”
Crystal Growth & Design, vol. 11, no. 5, pp. 1689–1696, 2011.
[42] L. Argueta-Figueroa, N. Torres-Gómez, R. García-Contreras
et al., “Hydrothermal synthesis of pyrrhotite (Fex-1S) nano-
plates and their antibacterial, cytotoxic activity study,” Prog-
ress in Natural Science: Materials International, vol. 28, no. 4,
pp. 447–455, 2018.
[43] M. A. Wikler, Methods for Dilution Antimicrobial Suscepti-
bility Tests for Bacteria That Grow Aerobically, National
Committee for Clinical Laboratory Standards, 2009.
[44] O. N. Shebanova and P. Lazor, “Raman study of magne-
tite (Fe3O4): laser-induced thermal effects and oxidation,”
Journal of Raman Spectroscopy, vol. 34, no. 11, pp. 845–
852, 2003.
[45] O. N. Shebanova and P. Lazor, “Raman spectroscopic study of
magnetite (FeFe2O4): a new assignment for the vibrational
spectrum,” Journal of Solid State Chemistry, vol. 174, no. 2,
pp. 424–430, 2003.
[46] N. Boucherit, A. Hugot-Le Goff, and S. Joiret, “Raman studies
of corrosion films grown on Fe and Fe-6Mo in pitting condi-
tions,” Corrosion Science, vol. 32, no. 5-6, pp. 497–507, 1991.
[47] T. Ohtsuka, K. Kubo, and N. Sato, “Raman spectroscopy of
thin corrosion films on iron at 100 to 150 C in air,” Corrosion,
vol. 42, no. 8, pp. 476–481, 1986.
[48] D. Thierry, D. Persson, C. Leygraf, N. Boucherit, and
A. Hugot-Le Goff, “Raman spectroscopy and XPS investiga-
tions of anodic corrosion films formed on FeMo alloys in
alkaline solutions,” Corrosion Science, vol. 32, no. 3, pp. 273–
284, 1991.
[49] D. L. A. De Faria, S. Venâncio Silva, and M. T. De Oliveira,
“Raman microspectroscopy of some iron oxides and oxyhydr-
oxides,” Journal of Raman Spectroscopy, vol. 28, no. 11,
pp. 873–878, 1997.
[50] J. M. Li, A. C. H. Huan, L. Wang, Y. W. Du, and D. Feng,
“Interface effects on magnetoresistance and magnetic-field-
reduced Raman scattering in magnetite,” Physical Review B,
vol. 61, no. 10, pp. 6876–6878, 2000.
[51] D. Bersani, P. P. Lottici, and A. Montenero, “Micro-Raman
investigation of iron oxide films and powders produced by
sol–gel syntheses,” Journal of Raman Spectroscopy, vol. 30,
no. 5, pp. 355–360, 1999.
[52] R. M. Cornell and U. Schwertmann, The Iron Oxides:
Structure, Properties, Reactions, Occurrences and Uses, John
Wiley & Sons, Second edition, 2003.
[53] H. Borchert, E. V. Shevchenko, A. Robert et al., “Determina-
tion of nanocrystal sizes: a comparison of TEM, SAXS, and
XRD studies of highly monodisperse CoPt3 particles,” Lang-
muir, vol. 21, no. 5, pp. 1931–1936, 2005.
[54] M. J. Yacamán, J. A. Ascencio, H. B. Liu, and
J. Gardea-Torresdey, “Structure shape and stability of nano-
metric sized particles,” Journal of Vacuum Science & Technol-
ogy B: Microelectronics and Nanometer Structures Processing,
Measurement, and Phenomena, vol. 19, no. 4, pp. 1091–
1103, 2001.
[55] T. K. Sau and A. L. Rogach, “Nonspherical noble metal
nanoparticles: colloid-chemical synthesis and morphology
control,” Advanced Materials, vol. 22, no. 16, pp. 1781–
1804, 2010.
[56] S. Arokiyaraj, M. Saravanan, N. K. Udaya Prakash, M. Valan
Arasu, B. Vijayakumar, and S. Vincent, “Enhanced antibacte-
rial activity of iron oxide magnetic nanoparticles treated with
Argemone mexicana L. leaf extract: an in vitro study,” Mate-
rials Research Bulletin, vol. 48, no. 9, pp. 3323–3327, 2013.
[57] J. Rejman, V. Oberle, I. S. Zuhorn, and D. Hoekstra, “Size-
dependent internalization of particles via the pathways of
clathrin-and caveolae-mediated endocytosis,” Biochemical
Journal, vol. 377, no. 1, pp. 159–169, 2004.
[58] M. J. Hajipour, K. M. Fromm, A. Akbar Ashkarran et al.,
“Antibacterial properties of nanoparticles,” Trends in Biotech-
nology, vol. 30, no. 10, pp. 499–511, 2012.
[59] N. Tran, A. Mir, D. Mallik, A. Sinha, S. Nayar, and T. Webster,
“Bactericidal effect of iron oxide nanoparticles on Staphylococ-
cus aureus,” International Journal of Nanomedicine, vol. 2010,
no. 5, pp. 277–283, 2010.
[60] S. M. El-Sigeny and M. F. Abou Taleb, “Synthesis, characteri-
zation, and application of dendrimer modified magnetite
nanoparticles as antimicrobial agent,” Life Science Journal,
vol. 12, no. 6, pp. 161–170, 2015.
[61] T. K. Indira and P. K. Lakshmi, “Magnetic nanoparticles–a
review,” International Journal of Pharmaceutical Sciences and
Nanotechnology, vol. 3, no. 3, pp. 1035–1042, 2010.
[62] M. Yaaghoobi, G. Emtiazi, and R. Roghanian, “A novel
approach for aerobic construction of iron oxide nanoparticles
by acinetobacter radioresistens and their effects on red blood
cells,” Current Nanoscience, vol. 8, no. 2, pp. 286–291, 2012.
[63] S. Klein, A. Sommer, L. V. R. Distel, W. Neuhuber, and
C. Kryschi, “Superparamagnetic iron oxide nanoparticles as
radiosensitizer via enhanced reactive oxygen species forma-
tion,” Biochemical and Biophysical Research Communications,
vol. 425, no. 2, pp. 393–397, 2012.
[64] L. Kou, J. Sun, Y. Zhai, and Z. He, “The endocytosis and
intracellular fate of nanomedicines: implication for rational
design,” Asian Journal of Pharmaceutical Sciences, vol. 8,
no. 1, pp. 1–10, 2013.
[65] S. Shanehsazzadeh, M. A. Oghabian, F. J. Daha, M. Amanlou,
and B. J. Allen, “Biodistribution of ultra small superparamag-
netic iron oxide nanoparticles in BALB mice,” Journal of
Radioanalytical and Nuclear Chemistry, vol. 295, no. 2,
pp. 1517–1523, 2013.
[66] G. L. Szeto and E. B. Lavik, “Materials design at the interface of
nanoparticles and innate immunity,” Journal of Materials
Chemistry B, vol. 4, no. 9, pp. 1610–1618, 2016.
14 Journal of Nanomaterials
[67] O. Ziv, R. R. Avtalion, and S. Margel, “Immunogenicity of
bioactive magnetic nanoparticles: natural and acquired anti-
bodies,” Journal of Biomedical Materials Research Part A,
vol. 85, no. 4, pp. 1011–1021, 2008.
[68] O. Ziv, T. Lublin-Tennenbaum, and S. Margel, “Synthesis and
characterization of thrombin conjugated γ-Fe2O3 magnetic
nanoparticles for hemostasis,” Advanced Engineering Mate-
rials, vol. 11, no. 12, pp. B251–B260, 2009.
[69] J. J. Hue, H. J. Lee, S. Jon et al., “Distribution and accumulation
of Cy5. 5-labeled thermally cross-linked superparamagnetic
iron oxide nanoparticles in the tissues of ICR mice,” Journal
of Veterinary Science, vol. 14, no. 4, pp. 473–479, 2013.
[70] H. Arami, A. Khandhar, D. Liggitt, and K. M. Krishnan, “In
vivo delivery, pharmacokinetics, biodistribution and toxicity
of iron oxide nanoparticles,” Chemical Society Reviews,
vol. 44, no. 23, pp. 8576–8607, 2015.
[71] N. Singh, G. J. S. Jenkins, R. Asadi, and S. H. Doak, “Potential
toxicity of superparamagnetic iron oxide nanoparticles
(SPION),” Nano Reviews, vol. 1, no. 1, p. 5358, 2010.
[72] D. Couto, M. Freitas, F. Carvalho, and E. Fernandes,
“Iron oxide nanoparticles: an insight into their biomedical
applications,” Current Medicinal Chemistry, vol. 22, no. 15,
pp. 1808–1828, 2015.
[73] S. Sharifi, H. Seyednejad, S. Laurent, F. Atyabi, A. A. Saei, and
M. Mahmoudi, “Superparamagnetic iron oxide nanoparticles
for in vivo molecular and cellular imaging,” Contrast Media
& Molecular Imaging, vol. 10, no. 5, pp. 329–355, 2015.
[74] K. Müller, J. N. Skepper, M. Posfai et al., “Effect of ultrasmall
superparamagnetic iron oxide nanoparticles (Ferumoxtran-
10) on human monocyte-macrophages in vitro,” Biomaterials,
vol. 28, no. 9, pp. 1629–1642, 2007.
[75] H. S. Han, J. D. Martin, J. Lee et al., “Spatial charge configura-
tion regulates nanoparticle transport and binding behavior
in vivo,” Angewandte Chemie International Edition, vol. 52,
no. 5, pp. 1414–1419, 2013.
[76] R. Kumar, I. Roy, T. Y. Ohulchanskky et al., “In vivo biodistri-
bution and clearance studies using multimodal organically
modified silica nanoparticles,” ACS Nano, vol. 4, no. 2,
pp. 699–708, 2010.
[77] T. K. Jain, M. K. Reddy, M. A. Morales, D. L. Leslie-Pelecky,
and V. Labhasetwar, “Biodistribution, clearance, and biocom-
patibility of iron oxide magnetic nanoparticles in rats,”Molec-
ular Pharmaceutics, vol. 5, no. 2, pp. 316–327, 2008.
[78] P. Bourrinet, H. H. Bengele, B. Bonnemain et al., “Preclinical
safety and pharmacokinetic profile of ferumoxtran-10, an
ultrasmall superparamagnetic iron oxide magnetic resonance
contrast agent,” Investigative Radiology, vol. 41, no. 3,
pp. 313–324, 2006.
[79] C. C. Berry, S. Wells, S. Charles, and A. S. G. Curtis, “Dextran
and albumin derivatised iron oxide nanoparticles: influence on






















































































Submit your manuscripts at
www.hindawi.com
